R1 RCM Inc. (NASDAQ:RCM) Receives $15.41 Average PT from Brokerages

Shares of R1 RCM Inc. (NASDAQ:RCM - Get Free Report) have been assigned an average rating of "Hold" from the eighteen analysts that are currently covering the company, Marketbeat reports. Thirteen investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $15.41.

A number of research analysts have weighed in on RCM shares. Cantor Fitzgerald reiterated a "neutral" rating and set a $14.30 price objective on shares of R1 RCM in a research report on Friday, October 4th. TD Cowen reiterated a "hold" rating and set a $14.30 price objective (down previously from $20.00) on shares of R1 RCM in a research report on Monday, August 5th. Stephens cut shares of R1 RCM from an "overweight" rating to an "equal weight" rating in a research report on Thursday, August 1st. Robert W. Baird reiterated an "outperform" rating and set a $18.00 price objective on shares of R1 RCM in a research report on Tuesday, July 2nd. Finally, Truist Financial cut their price objective on shares of R1 RCM from $16.00 to $14.30 and set a "hold" rating on the stock in a research report on Thursday, August 8th.

Hedge Funds Weigh In On R1 RCM

Several hedge funds have recently modified their holdings of the stock. Values First Advisors Inc. acquired a new position in shares of R1 RCM during the third quarter valued at about $88,000. Allspring Global Investments Holdings LLC increased its holdings in R1 RCM by 589.2% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,122 shares of the healthcare provider's stock worth $44,000 after buying an additional 2,669 shares during the period. Creative Planning acquired a new position in R1 RCM in the 3rd quarter worth approximately $142,000. GAMMA Investing LLC increased its holdings in R1 RCM by 41.3% in the 3rd quarter. GAMMA Investing LLC now owns 2,597 shares of the healthcare provider's stock worth $37,000 after buying an additional 759 shares during the period. Finally, Bardin Hill Management Partners LP increased its holdings in R1 RCM by 98.7% in the 2nd quarter. Bardin Hill Management Partners LP now owns 525,211 shares of the healthcare provider's stock worth $6,597,000 after buying an additional 260,891 shares during the period. Institutional investors and hedge funds own 61.10% of the company's stock.

R1 RCM Price Performance

Shares of R1 RCM stock traded up $0.01 on Friday, hitting $14.25. 806,043 shares of the company traded hands, compared to its average volume of 3,555,952. The stock has a market capitalization of $6.00 billion, a P/E ratio of -178.13 and a beta of 0.85. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.84 and a current ratio of 1.84. R1 RCM has a 52 week low of $8.87 and a 52 week high of $15.12. The business has a 50-day simple moving average of $14.15 and a 200 day simple moving average of $13.18.

R1 RCM (NASDAQ:RCM - Get Free Report) last announced its quarterly earnings results on Wednesday, August 7th. The healthcare provider reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.03. R1 RCM had a negative net margin of 1.68% and a negative return on equity of 1.44%. The company had revenue of $627.90 million for the quarter, compared to analysts' expectations of $633.10 million. The business's quarterly revenue was up 12.0% compared to the same quarter last year. Research analysts expect that R1 RCM will post -0.24 earnings per share for the current fiscal year.

About R1 RCM

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.